Dr Agarwal's Health Care IPO: Check key dates, price band, latest GMP & other details
Dr Agarwal's Health Care will launch its IPO from January 29 to 31, aiming to raise Rs 3,027.26 crore. The IPO includes a fresh share sale and an OFS. The company specializes in eye care services. The grey market premium indicates strong demand, w...

The IPO of Dr Agarwal's Health Care includes a fresh share sale of Rs 300 crore, while an offer-for-sale (OFS) of up to 6,78,42,284 equity shares worth Rs 2,727.26 crore by its promoters and existing shareholders. At the upper end of the price band, the company is likely to raise a total of Rs 3,027.26 crore via IPO.
About Dr Agarwal's Health Care
Founded in 2010, Chennai-based Dr Agarwal's Health Care specializes in eye care services, offering cataract and refractive surgeries, consultations, diagnostics, non-surgical treatments, and sales of optical products, contact lenses, and eye care pharmaceuticals.
Also Read: Q3 results today: IndiGo, JSW Steel among 81 companies to announce earnings on Friday
Dr Agarwal's Health Care IPO: GMP today
The grey market activity signals strong demand, with today's GMP of Rs 90-100 indicating a potential listing premium of about 22%.
Dr Agarwal's Health Care net proceed
The net proceeds from the issue shall be utilized towards repayment/prepayment, in part or full, of certain of the borrowings; general corporate purposes; and unidentified inorganic acquisition. The anchor book for the issue shall open on Tuesday, January 28. Last heard, the company commanded a grey market premium of Rs 164 apiece, suggesting a 41 per cent gains for investors.
Also Read: JioCoin Launch: How to earn digital tokens and what it means for users
Dr Agarwal's Health Care listing and allotment date
The allotment for the IPO is expected to be finalised on February 3 and the listing of shares will be on February 5.
Dr Agarwal's Health Care financials
Also Read: RBI injects over Rs 1.5 lakh crore via VRR auctions, buybacks
Dr Agarwal's Health Care other details
The IPO has reserved 15,79,399 shares worth Rs 63.49 crore for eligible employees and 11,29,574 shares for shareholders of Dr Agarwal's Eye Hospital. Of the net offer, 50% is allocated to Qualified Institutional Bidders (QIBs), 35% to retail investors, and 15% to non-institutional bidders.
Kotak Mahindra Capital Company, Morgan Stanley India, Jefferies India, and Motilal Oswal Investment Advisors are the book-running lead managers for the IPO, with KFin Technologies acting as the registrar. Shares of the company shall be listed on both BSE and NSE.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
Download ET Markets APP